GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Albert David Ltd (BOM:524075) » Definitions » Gross Margin %

Albert David (BOM:524075) Gross Margin % : 62.85% (As of Dec. 2023)


View and export this data going back to 2000. Start your Free Trial

What is Albert David Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Albert David's Gross Profit for the three months ended in Dec. 2023 was ₹555 Mil. Albert David's Revenue for the three months ended in Dec. 2023 was ₹883 Mil. Therefore, Albert David's Gross Margin % for the quarter that ended in Dec. 2023 was 62.85%.

Warning Sign:

Albert David Ltd gross margin has been in long-term decline. The average rate of decline per year is -1.3%.


The historical rank and industry rank for Albert David's Gross Margin % or its related term are showing as below:

BOM:524075' s Gross Margin % Range Over the Past 10 Years
Min: 62.2   Med: 64.89   Max: 69.98
Current: 63.44


During the past 13 years, the highest Gross Margin % of Albert David was 69.98%. The lowest was 62.20%. And the median was 64.89%.

BOM:524075's Gross Margin % is ranked better than
77.71% of 987 companies
in the Drug Manufacturers industry
Industry Median: 46.24 vs BOM:524075: 63.44

Albert David had a gross margin of 62.85% for the quarter that ended in Dec. 2023 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Albert David was -1.30% per year.


Albert David Gross Margin % Historical Data

The historical data trend for Albert David's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Albert David Gross Margin % Chart

Albert David Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 64.93 66.09 64.26 62.39 63.04

Albert David Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 67.35 58.66 65.54 66.04 62.85

Competitive Comparison of Albert David's Gross Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Albert David's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Albert David's Gross Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Albert David's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Albert David's Gross Margin % falls into.



Albert David Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Albert David's Gross Margin for the fiscal year that ended in Mar. 2023 is calculated as

Gross Margin % (A: Mar. 2023 )=Gross Profit (A: Mar. 2023 ) / Revenue (A: Mar. 2023 )
=2143.3 / 3400.087
=(Revenue - Cost of Goods Sold) / Revenue
=(3400.087 - 1256.815) / 3400.087
=63.04 %

Albert David's Gross Margin for the quarter that ended in Dec. 2023 is calculated as


Gross Margin % (Q: Dec. 2023 )=Gross Profit (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=554.8 / 882.81
=(Revenue - Cost of Goods Sold) / Revenue
=(882.81 - 328.007) / 882.81
=62.85 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Albert David  (BOM:524075) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Albert David had a gross margin of 62.85% for the quarter that ended in Dec. 2023 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Albert David Gross Margin % Related Terms

Thank you for viewing the detailed overview of Albert David's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Albert David (BOM:524075) Business Description

Traded in Other Exchanges
Address
8, Netaji Subhas Road, D-Block, 3rd Floor, Gillander House, Kolkata, WB, IND, 700001
Albert David Ltd is engaged in the manufacturing and trading of pharmaceutical products. The company offers products such as pharmaceutical formulations, infusion solutions, herbal dosage forms, and bulk drugs. Its formulation product covers parenteral, oral, and enteral, topical agents, and vision care solutions. The company exports its product to regions like Latin America, South East Asia, and a few African countries.

Albert David (BOM:524075) Headlines

No Headlines